[1] Medzhitov R,Hurlburt P,Janeway CA. A human homologue of the drosophila Toll protein signals activation of adaptive immunity. Nature,1997,388（6640）:384-397.
[2] 李丽燕. Toll样受体的研究进展.临床医学工程,2011,18（3）：467-469.
[3] Wu J,Lu M,Meng Z,et al. Toll-like receptor-mediated control of HBV replication by nonparenchymal liver cells in mice.Hepatology,2007,46（6）：1769-1778.
[4] Isogawa M,Robek MD,Furuichi Y,et al. Toll-like receptor signaling inhibits hepatitis B virus replication in vivo. J Virol,2005,79（11）：7269-7272.
[5] 中华医学会肝病学分会和感染病学分会.慢性乙型肝炎防治指南（2010年版）. 实用肝脏病杂志,2011,14（2）：81-89.
[6] 刘勇. Toll样受体4介导非感染性免疫反应在器官功能损伤中的作用. 中国急救医学,2012,32（1）：76-79.
[7] Mozer-Lisewska J,Sluzewski W,Kackzmarek M,et al. Tissue localization of Toll-like receptor in biopsy specimens of liver from children infected with hepatitis C virus. Scand J Immunol,2005,62（4）:407-412.
[8] Manigold T,Bocker U,Hanck C,et al. Differential expression of toll-like receptors 2 and 4 in patients with liver cirrhosis. J Gastroenterol Hepatol,2003,15（3）:275-282.
[9] 尉秀清,郭云蔚,文卓夫,等. 慢性重型乙型肝炎患者外周血单个核细胞Toll样受体4的变化及其与IL-6的关系. 中国病理生理杂志,2007,23（8）：1563-1565.
[10] Schwartz DA. The role of TLR4 in endotoxin responsiveness in humans. Endotoxin Res,2001,7（1）:389-393.
[11] 刘伟,刘尚忠,蒋水英,等. 慢性乙型肝炎患者血清内毒素和PDGF水平的变化及意义. 临床肝胆病杂志,2009,25（1）:37-38.
[12] 张伟英,杨利华,卓凌,等. 慢性乙型肝炎患者血清TNF-α、IL-6和IL-10水平及其临床意义.国际检验医学杂志,2010,31（6）:120-121.
[13] 王友基,高建平. 乙型肝炎病毒感染者HBV DNA与IL-1、IL-6的关系及临床意义. 福建医药杂志,2010,32（6）:90-91.
[14] 田华.乙型肝炎病毒感染者血清3种细胞因子水平及其临床意义. 检验医学与临床,2009,1（6）:136-137. |
